Skip to main content
OpenTrials
Completed

NCT Number: NCT05071495

TeleDiet Study: The Impact of Dietary Education and Counseling With a Smartphone Application on Secondary Prevention of Coronary Artery Disease

Digital cardiology is gaining power in the field of preventive cardiology recently, and several trials have already shown good results of dietary therapy with digital cardiology. However, there has been no reports that showed effect of dietary counseling through digital cardiology for secondary prevention of coronary artery disease.

TeleDiet study investigates the impact of dietary therapy with a smartphone application on the content of meals and metabolic parameters for patients with coronary artery disease.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Coronary Artery Disease Arterial Occlusive Diseases Arteriosclerosis Cardiovascular Diseases Coronary Disease Heart Diseases Myocardial Ischemia Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Jessa Hospital

Hasselt, Limburg, 3500, Belgium

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Owning a smartphone and able to use it
  • Written informed consent obtained
  • Starting cardiac rehabilitation
  • Coronary artery disease

Exclusion criteria

  • Special diet due to other reasons (eg. renal diet, pancreatic insufficiency diet)
  • Age <18 years old
  • Pregnancy

Treatment and study plan

Smartphone application

Device

Smartphone application named "Signal", which connects patients and health providers

Primary outcomes

  1. MedDiet score (the Mediterranean diet score)

    Time frame: Up to 3 months

    This score has the extreme values of 0 (minimum) and 55 (maximum). Higher scores mean a better outcome.

Secondary outcomes

  1. Blood lipid tests (LDL-cholesterol [LDL-C], HDL-cholesterol [HDL-C], and triglyceride [TG])

    Time frame: Up to 3 months

  2. Blood glycated hemoglobin (HbA1c) test

    Time frame: Up to 3 months

  3. Blood creatinine (Cr) test

    Time frame: Up to 3 months

  4. Parameters in the ergospirometer test (maximal oxygen consumption [VO2 max])

    Time frame: Up to 3 months

  5. Parameters in the ergospirometer test (anaerobic threshold [AT])

    Time frame: Up to 3 months

  6. Values of self-efficacy (questionnaire of General Self-Efficacy Scale [GSE])

    Time frame: Up to 3 months

    This scale has the extreme values of 10 (minimum) and 40 (maximum). Higher scores mean a better outcome.

  7. Values of medication adherence (questionnaire of Identification of Medication Adherence Barriers [IMAB])

    Time frame: Up to 3 months

    This scale has the extreme values of 30 (minimum) and 150 (maximum). Higher scores mean a worse outcome.

  8. Values of quality of life (Health-related Quality of Life questionnaire [HeartQoL])

    Time frame: Up to 3 months

    This scale has the extreme values of 0 (minimum) and 42 (maximum). Higher scores mean a better outcome.

  9. Body weight (BW)

    Time frame: Up to 3 months

  10. Body mass index (BMI)

    Time frame: Up to 3 months

    Weight and height will be combined to report BMI in kg/m^2.

Sponsors and collaborators

Lead sponsor

Jessa Hospital

Other

Registry information

Official study title

TeleDiet Study: A Randomized Controlled Study Investigating the Impact of Dietary Education and Counseling With a Smartphone Application on Secondary Prevention of Coronary Artery Disease

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
Oct 8, 2021
Registry last updated
Sep 7, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.